TWiV 967: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses how immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Immunological dysfunction persists for 8 months following SARS-CoV-2 infection (Nature) Prevalence of SARS-CoV-2 and Influenza coinfection and clinical characteristics (CDC) WHO estimates of excess mortality associated with the COVID-19 pandemic (Nature) Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection (OFID) Impact of SARS-CoV-2 variants on inpatient clinical outcome (CID) Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection (OFID) Similar SARS-CoV-2 Ct value distributions in samples from symptomatic children (JPIDS) Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19 (CDC) Effect of Nirmatrelvir/Ritonavir vs placebo on COVID-19─Related hospitalizations (OFID) COVID-19 Convalescent Plasma outpatient therapy to prevent outpatient hospitalization (MedRxiv) Bacterial co-infection and empirical antibiotic therapy in patients with COVID-19 (OFID) Association of time to surgery after COVID-19 infection (JAMA) Demonstration of stable clusters of symptoms in long COVID (OFID) Paxlovid patient eligbiliity screening checklist (FDA) Longitudinal analysis of T cells in COVID-19 survivors with post-acute sequelae (OFID) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin’s treatment guide (pdf) Letters read on TWiV 967 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]